Oral Clinical Nutrition Market size to exceed USD 54 Billion by 2034

Selbyville, DE. - The global oral clinical nutrition market was estimated at USD 32.2 billion in 2024 and is estimated to grow from USD 33.2 billion in 2025 to USD 54 billion by 2034, at a CAGR of 5.5%, according to the latest report published by Global Market Insights Inc.   

Conditions like cancer, diabetes, gastrointestinal disorders, and COPD increase the need for nutritional management. Oral clinical nutrition products are commonly used to support recovery and maintain nutritional status.

Key Insights:

Market Size & Growth:

• 2024 Market Size: USD 32.2 billion  
• 2025 Market Size: USD 33.2 billion  
• 2034 Forecast Market Size: USD 54 billion  
• CAGR (2025–2034): 5.5%  

• Regional Insights:

• Largest Market: North America  
• Fastest Growing Market: Asia Pacific  
• Emerging Countries: India, South Korea, Brazil, Mexico, Saudi Arabia, UAE  

• Key Growth Drivers:

1. Aging population: The global rise in the elderly population is a major driver.  
2. Increasing hospital admissions and home care: As more patients are discharged early from hospitals, there is a greater demand for oral clinical nutrition in home care settings.  
3. Growing awareness of disease-related malnutrition: Healthcare professionals and caregivers are increasingly recognizing the importance of addressing malnutrition in clinical settings, driving prescription and recommendation of oral nutrition supplements (ONS).  
4. Product innovation and customization: Manufacturers are introducing tailored solutions such as high-protein, fiber-enriched, lactose-free, or condition-specific products (e.g., renal or diabetic formulas), which meet patient needs more precisely and expand market scope.  
5. Supportive government and reimbursement policies: In many countries, oral clinical nutrition products are covered under public or private health insurance schemes, encouraging their use in hospitals and long-term care facilities.  

• Key Players:

• Abbott led the market with over 35% share in 2024.  
• Some of the top players in this market include Danone, Nestle Health Science, and Abbott (Abbott Nutrition), which together held a 55-60% share in 2024.  

• Key Challenges:

1. Low patient compliance: Taste fatigue, texture issues, and lack of appetite often lead to poor adherence, especially in long-term use.  
2. High cost of specialized products: Condition-specific formulas (e.g., for cancer or renal patients) can be expensive, limiting accessibility without strong reimbursement support.  
3. Limited reimbursement in some regions: In many developing countries and even some developed markets, oral nutrition supplements are not fully covered by insurance, reducing their uptake.  
4. Regulatory variability: Differing regulations across countries regarding product classification (food vs. medicine) create barriers to entry and expansion.  
5. Lack of awareness among patients and caregivers: Many patients and even caregivers are unaware of the role and benefits of clinical nutrition, leading to underutilization.  

Browse key industry insights spread across 135 pages with 204 market data tables and figures from the report, “Oral Clinical Nutrition Market – By Product, By Consumer, By Application, By Dosage Form, By Distribution Channel – Global Forecast, 2025 – 2034” in detail, along with the table of contents:  

https://www.gminsights.com/industry-analysis/oral-clinical-nutrition-market  

Rising Use of Standard Formula

The standard formula segment held a sustainable share in 2024, driven by its versatility in addressing a wide range of general nutritional needs. These formulas are used for patients who do not require condition-specific formulations but still need calorie-dense and nutrient-rich supplements. Hospitals, outpatient clinics, and long-term care facilities routinely prescribe standard formulas for post-operative recovery, short-term malnutrition, and general dietary support.  

Increasing Adoption Among Adults

The adult segment held a sizeable share in 2024, owing to the rising incidence of chronic illnesses, aging-related nutritional challenges, and growing awareness around disease-related malnutrition. Adults undergoing cancer therapy, recovering from surgery, or managing conditions like diabetes and gastrointestinal disorders often require oral nutrition support to maintain body mass and functional status.  

Malnutrition to Gain Traction

The malnutrition segment generated notable revenues in 2024, backed by clinical and elderly care settings. Despite being a preventable and treatable condition, malnutrition remains underdiagnosed, especially among older adults and patients with chronic illnesses. The market has seen a surge in demand for targeted oral nutrition supplements designed to address protein-energy malnutrition and micronutrient deficiencies.  

North America to Emerge as a Lucrative Region

North America oral clinical nutrition market is poised to witness a decent CAGR during 2025-2034, driven by an aging population, high healthcare expenditure, and robust clinical infrastructure. The presence of major market players, combined with favorable reimbursement policies and well-established distribution networks, further fuels regional growth. In addition, increasing public and professional awareness of the importance of nutrition in managing chronic diseases has accelerated the adoption of oral nutrition supplements.  

Major players operating in the oral clinical nutrition industry include Meiji Holdings, Pfizer, Nutriset, Abbott Nutrition, Otsuka Pharmaceutical, Kate Farms, B. Braun, GlaxoSmithKline, Nestle Health Science, AYMES Nutrition, Danone, Medifood International, Fresenius Kabi, and Mead Johnson (Reckitt).  

To strengthen their foothold in the oral clinical nutrition market, companies are pursuing a mix of product innovation, strategic partnerships, and geographic expansion. Leading manufacturers are investing heavily in R&D to develop condition-specific formulations that cater to the unique dietary needs of patients with diabetes, renal disease, or cancer. Additionally, brands are focusing on taste improvement and convenience, such as ready-to-drink formats, to boost patient compliance. Strategic collaborations with hospitals, home healthcare providers, and insurance companies have helped extend market reach and improve product accessibility. These strategies collectively enable companies to maintain a competitive advantage while addressing the evolving nutritional demands of diverse patient populations.